Vaccine Adjuvants Market Research and Forecast Report 2023-2028

1. Global Vaccine Adjuvants Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Vaccine Adjuvants Market Research Report: The latest report by IMARC, titled “Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” finds that the global vaccine adjuvants market size reached US$ 884 Million in 2022. Vaccine adjuvants are compounds that improve the body’s immunogenic response against antigens. They increase the ability of the vaccines to induce long-term protection against infections. Presently, aluminum salts and MF59 are the only adjuvants found fit for human use. In recent years, the demand for vaccine adjuvants has escalated as they increase antibody titers, reduce required antigen doses, induce a rapid immune response and long-lasting memory, and enhance the immune response in the elderly and young children. Request market/requestsample Free Sample Report: https://www.imarcgroup.com/vaccine-adjuvants-

4. Report Description and Highlights Report Description Global Vaccine Adjuvants Market Trends: One of the primary factors driving the market is the rising incidences of infectious diseases and allergies, such as human immunodeficiency virus (HIV/AIDS), cancer, human papillomavirus (HPV), and tuberculosis. Additionally, the need for advanced treatment options for prevailing and emerging fatal diseases has increased the need to develop vaccines possessing long-lasting effects on immunization. Other than this, governments of numerous nations are taking initiatives for immunization and improvements in adjuvants for human consumption. They are also focusing on enhancing the healthcare infrastructure and increasing investments in research and development (R&D) of new therapeutics, which is creating a positive market outlook. Furthermore, with the sudden coronavirus (COVID-19) outburst, the demand for effective and safe vaccine adjuvants is constantly increasing. On account of these factors, IMARC Group expects the market value to reach US$ 1,812 Million by 2028, expanding at a CAGR of 12.4% during the forecast period (2023-2028). Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Breakup by Product Type: • Adjuvant Emulsions • Pathogen Components • Particulate Adjuvants • Combination Adjuvants • Others Breakup by Route of Administration: • Oral • Intramuscular • Intranasal • Subcutaneous • Intradermal • Others Breakup by Diseases: • Cancer • Infectious Diseases

6. Report Description and Highlights Report Description • Others Breakup by Application: • Research • Commercial Breakup by Region: • North America • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany

7. Report Description and Highlights Report Description • France • United Kingdom • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • Adjuvance Tecchnologies Inc. Adjuvatis Agenus Inc. Brenntag SE Chemtrade Logistics Inc. CSL Limited Croda International Plc Invivogen Novavax Inc. OZ Biosciences Virometix AG View Full Report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-adjuvants-market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com